ARCT vs HUM · rev $5.0M vs P/E 39, rev $129.66B
Arcturus Therapeutics Holdings Inc (ARCT) versus Humana Inc (HUM) — a side-by-side from cached financials, not a winner call.
Arcturus Therapeutics Holdings Inc (ARCT) is a biotechnology company listed on US.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Latest reported ARCT revenue for 2026-06-30 was $5.0M. Net income was -$50.7M. ARCT currently screens at market cap $369.4M.
Latest reported HUM revenue for 2025-12-31 was $129.66B. Net income was $1.19B. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
ARCT currently screens at market cap $369.4M. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Not investment advice. Open the ARCT and HUM stock pages for the full models.
Not investment advice.